BankPlus Trust Department’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$412K Buy
9,648
+180
+2% +$9.77K 0.1% 139
2026
Q1
$594K Sell
9,468
-386
-4% -$30.9K 0.16% 115
2025
Q4
$940K Buy
9,854
+58
+0.6% +$5.69K 0.25% 87
2025
Q3
$956K Sell
9,796
-375
-4% -$38.8K 0.26% 79
2025
Q2
$1.09M Buy
10,171
+1,776
+21% +$180K 0.32% 70
2025
Q1
$847K Buy
8,395
+157
+2% +$15.8K 0.28% 74
2024
Q4
$736K Buy
+8,238
New +$725K 0.24% 84

Other funds holding BSX

BankPlus Trust Department's BSX Position: Q2 2026 in Review

BankPlus Trust Department increased its Boston Scientific (BSX) stake by 1.9% in Q2 2026, buying an estimated $9.77K and bringing the position to 9,648 shares worth $412K. The position accounts for 0.1% of the portfolio, ranked #139.

BankPlus Trust Department first reported a position in BSX in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.09M in Q2 2025. 1,487 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • BankPlus Trust Department held 9,648 shares of Boston Scientific worth $412K as of Q2 2026.
  • BankPlus Trust Department bought 180 Boston Scientific shares in Q2 2026, an estimated $9.77K.
  • Boston Scientific made up 0.1% of BankPlus Trust Department's portfolio in Q2 2026, its #139 holding.
  • BankPlus Trust Department first reported a position in Boston Scientific in Q4 2024 and has held it in 7 quarters since.
  • BankPlus Trust Department's Boston Scientific position peaked at $1.09M in Q2 2025.
  • 1,487 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on BankPlus Trust Department's 13F filing for Q2 2026, filed 28 Jul 2026.